169 research outputs found
Four new HgMn stars: HD 18104, HD 30085, HD 32867, HD 53588
We have detected four new HgMn stars, while monitoring a sample of apparently
slowly rotating superficially normal bright late B and early A stars in the
northern hemisphere. Important classification lines of Hg II and Mn II are
found as conspicuous features in the high resolution SOPHIE spectra of these
stars (R = 75000). Several lines of Hg II, Mn II and Fe II have been
synthesized using model atmospheres and the spectrum synthesis code SYNSPEC48
including hyperfine structure of various isotopes when relevant. These
synthetic spectra have been compared to high resolution high signal-to-noise
observations of these stars in order to derive abundances of these key
elements. The four stars are found to have distinct enhancements of Hg and Mn
which show that these stars are not superficially normal B and A stars, but
actually are new HgMn stars and should reclassified as such.Comment: 4 pages, 3 figures, accepted in A&
Principal component analysis-based inversion of effective temperatures for late-type stars
We show how the range of application of the principal component
analysis-based inversion method of Paletou et al. (2015) can be extended to
late-type stars data. Besides being an extension of its original application
domain, for FGK stars, we also used synthetic spectra for our learning
database. We discuss our results on effective temperatures against previous
evaluations made available from Vizier and Simbad services at CDS.Comment: Accepted for publication in A&
Formation of Pancreatoduodenal Fistula in Intraductal Papillary Mucinous Neoplasm of the Pancreas Decreased the Frequency of Recurrent Pancreatitis
Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are characterized by proliferation of mucin-secreting cells in the main pancreatic duct (PD) or its branches. The secreted thick mucin usually leads to PD obstruction and dilation. A common complication of IPMN is recurrent acute pancreatitis secondary to poor pancreatic fluid drainage, and rarely, pancreatobiliary and pancreatointestinal fistulae. We describe a unique case of IPMN in a 57-year-old male who was referred to our institution for evaluation of recurrent acute pancreatitis. After extensive evaluation, he was diagnosed with main duct IPMN. Intraductal PD biopsy revealed intestinal type IPMN with intermediate grade dysplasia. Patient was managed clinically by large caliber (10 French) PD stenting which eliminated his recurrent acute pancreatitis. The patient was initially referred for pancreatic resection; however, surgery was aborted and evaluated to be high risk with high morbidity secondary to the extensive adhesions between the pancreas and surrounding structures. Patient remained clinically stable for a few years except for an episode of acute pancreatitis that happened after a trial of stent removal. Subsequently, the patient did well after the PD stent was replaced. Recently, repeat abdominal imaging revealed a large pancreatoduodenal fistula which was confirmed on repeat endoscopic retrograde cholangiopancreatography. We were able to perform pancreatoscopy by advancing a regular upper scope through the fistula and into the PD. Interestingly, the fistula relieved the symptoms of obstruction and subsequently decreased the frequency of recurrent pancreatitis episodes with no further episodes at 6 months follow-up. This case highlights the importance of providing adequate PD drainage to reduce the frequency of recurrent acute pancreatitis in the setting of main duct IPMN, especially if the patient is not a surgical candidate. Also, physicians need to monitor for complications such as fistula formation between the pancreas and surrounding structures in the setting of chronic inflammation due to recurrent episodes of pancreatitis. Early identification of a fistula is important for surgical planning. Furthermore, since recent studies suggested a higher incidence of additional primary malignancies in patients with IPMN of the pancreas compared to the general population, patients may be considered for screening for other primary malignancies
- …